CONSULTOR MEDICO CIENTIFICO TUMORES RAROS - MEDICAL SCIENCE LIAISON - (MSL) - Barueri/SP

优缺点分析

角色解读

• Progress to Senior MSL or Lead MSL overseeing a therapeutic area or regional team.
• Move into Medical Affairs management roles (Medical Director, Head of Medical) within the company.
• Transition to clinical development or regulatory affairs with deep scientific expertise.
• Act as the primary scientific contact for rare tumor specialists, providing up-to-date medical information and education.
• Spend 80% of time in the field visiting KOLs, hospitals, and research centers to discuss clinical data and ongoing trials.
• Support internal teams (commercial, access) with scientific expertise and help identify research opportunities.
• Mentor junior MSLs and contribute to strategic planning and competitive intelligence.
• Advanced degree (Master/PhD/PharmD/MD) in health sciences with deep knowledge of oncology and rare diseases.
• Previous MSL or clinical research experience in the pharmaceutical industry.
• Fluent English for global communication and scientific literature review.
• Strong interpersonal and mentoring abilities to influence stakeholders and guide colleagues.

申请策略

• Tailor your CV to reflect the 'strategic partner' aspect of the MSL role.
• Demonstrate understanding of Brazilian healthcare system and rare disease patient journey.
• Emphasize MSL-specific experience and achievements in rare disease or oncology.
• Highlight advanced degree and any research publications or clinical trial involvement.
• Showcase language proficiency (English) and cross-functional collaboration examples.
• Include mentoring or leadership experiences, even if informal.
• Deepen knowledge of rare tumors and current treatment guidelines.
• Familiarize with Veeva CRM or similar field reporting tools.

面试指南

• Use the STAR method (Situation, Task, Action, Result) for behavioral questions.
• For scientific questions, demonstrate structured thinking: background, evidence evaluation, impact on practice.
• Show alignment with company values: patient-centric, curious, integrity.
• How do you stay current with scientific literature and translate it into meaningful HCP interactions?
• Describe a situation where you successfully influenced a KOL's perspective on a new therapy.
• How would you handle a discrepancy between a KOL's view and company strategy while maintaining compliance?
• Explain your approach to mentoring a junior MSL who is struggling with territory management.
• What steps would you take to identify and engage a new thought leader in a specific rare tumor type?